Old Web
English
Sign In
Acemap
>
authorDetail
>
Makimoto Hiroo
Makimoto Hiroo
MAPK/ERK pathway
HaCaT
Sunitinib
Sorafenib
Cancer research
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
医師主導治験の実施支援並びに我が国の治験推進に関する研究 アルベカシンのデュシェンヌ型筋ジストロフィー患者に対する安全性,ナンセンス変異のリードスルー作用に基づく有効性の検討を目的としたプラセボ対照無作為化試験
2015
Takeshima Yasuhiro
Matsuo Masafumi
Iijima Kazumoto
Hirai Midori
Komaki Hirofumi
Nonomura Sadaaki
Matsuda Ryoichi
Shiozuka Masataka
Kume Manabu
Makimoto Hiroo
Ri Tomoko
Show All
Source
Cite
Save
Citations (0)
Effects of sorafenib and sunitinib on MAPK activation in HaCaT cells and effects of MAPK inhibitor on sorafenib and sunitinib-induced cell growth inhibition and signal transduction.
2014
PLOS ONE
Yamamoto Kazuhiro
Mizumoto Atsushi
Nishimura Kohji
Uda Atsushi
Mukai Akira
Yamashita Kazuhiko
Kume Manabu
Makimoto Hiroo
Bito Toshinori
Nishigori Chikako
Nakagawa Tsutomu
Hirano Takeshi
Hirai Midori
Show All
Source
Cite
Save
Citations (0)
1